The Directorate General of Trade Remedies has recommended the duty after its investigation concluded that APIs from China have been exported to India at dumped prices, which has affected the domestic industry.
The commerce ministry has recommended imposition of anti-dumping duty on a pharma raw material – Ceftriaxone Sodium Sterile – from China to protect domestic companies from cheap imports.
The Directorate General of Trade Remedies (DGTR) has recommended the duty after its investigation concluded that APIs (Active Pharma Ingredient) from China have been exported to India at dumped prices, which has affected the domestic industry.
“The Authority recommends imposition of anti-dumping duty on the import of the subject goods…,” the directorate said in a notification.
Ceftriaxone Sodium Sterile is an API used to treat diseases such as lower respiratory tract infections, infections of the skin and skin structure, and surgical prophylaxis.
The DGTR had conducted an inquiry into the dumping of the chemical following complaints from Nectar Life Sciences and Sterile India.
The recommended fee is $12.91 per kilogram. The Finance Ministry takes the final decision on levying the duty.
In a separate notification, the DGTR has said that it has initiated a sunset review inquiry to review the need for continuation of anti-dumping duty on aluminum foil from China.
Anti-dumping duty is allowed under the World Trade Organization (WTO) regime.
The duty is aimed at ensuring fair trade practices and providing equal opportunities for domestic producers as compared to foreign producers and exporters.
.